No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer

byWinnie Liu

July 5, 2023

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Nivolumab plus ipilimumab improves survival over lenvatinib or sorafenib in liver cancer

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

Whole-person assessments may not yet be suitable for general practice

RelatedReports

StudyGraphics

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

June 19, 2025

Prognostic indicators for transarterial chemoembolization in patients with hepatocellular carcinoma with extrahepatic spread identified

AI Roundup

Nivolumab plus ipilimumab improves survival over lenvatinib or sorafenib in liver cancer

June 12, 2025

Pharma

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

June 4, 2025

Lessons from real-world implementation of lung cancer screening

Chronic Disease

Ivonescimab improves survival in advanced non-small cell lung cancer

April 30, 2025

#VisualAbstract: 24-hour ambulatory blood pressure better predicts all-cause mortality than clinic blood pressure

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Nirmatrelvir-ritonavir is effective in reducing COVID-19-related hospitalization

Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Hemodynamic monitoring improves quality of life and reduces hospitalizations in heart failure patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result